Cargando…
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Autores principales: | Monti, Sara, Balduzzi, Silvia, Delvino, Paolo, Bellis, Elisa, Quadrelli, Verdiana Serena, Montecucco, Carlomaurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211079/ https://www.ncbi.nlm.nih.gov/pubmed/32241793 http://dx.doi.org/10.1136/annrheumdis-2020-217424 |
Ejemplares similares
-
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse
por: Monti, Sara, et al.
Publicado: (2020) -
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis
por: Bartoletti, Alice, et al.
Publicado: (2023) -
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target
por: Bugatti, Serena, et al.
Publicado: (2021) -
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis
por: Favalli, Ennio Giulio, et al.
Publicado: (2020) -
Rheumatoid arthritis treatment: the earlier the better to prevent joint damage
por: Monti, Sara, et al.
Publicado: (2015)